The new gel is currently being developed as a contraceptive and is expected to be available in the next three years.
The drug is injected into vas deferns-the tube that sperm passes through on the way to the penis. It temporarily blocks the tubes via which the sperm flows from a man’s testicles.
Vasalgel has been tested on 10-15 female baboons, and no pregnancy was reported in the past six months.
Vasalgel is being produced by the actual Parsemus Groundwork; the non-profit organization. Vasalgel is usually a hydro gel.
Parsemus Foundation plans to test it on humans by next year. If the test is successful, it will revolutionize birth control as men would no longer have to wear a condom and women can opt out of the pill.
This is the second round of baboon orgies for Vasalgel, as the first round failed poorly.
The injection will require to be taken just above the testicles. Parsemus calls the process “similar to a no-scalpel vasectomy.” It is hoped that the gel will be “more reversible” than a vasectomy — the substance would get “flushed out” with another injection.
The product is based on another male contraceptive being developed, which is called RISUG.
Both RISUG and Vasalgel work on the principle of using a gel to block the vas deferens, but are formulated differently.
Parsemus aims to produce the brand new economical man contraceptive, reversible, and also long-lasting.
“We want to get Vasalgel on the market as soon as possible, but all the proper efficacy and safety testing needs to be completed,” said a spokesperson for Parsemus Foundation.
This will be a great discovery keeping in view the condom method’s failure rate is 18 percent with common use. Vasalgel is 100 percent effective, it does not provide someone protection from STDs and HIV.
The Parsemus Foundation will be asking for public donations to fund the clinical trials on humans next year.